Fundraising Fox
Cytek Biosciences
NASDAQ: CTKBUnicorn · $2.2BBellevue, US · Delaware corporation · 454 employees on LinkedIn · 4 known investors
Find your way into Cytek Biosciences
Sign up to see every warm intro you have to Cytek Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cytek Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets. The company serves the life sciences research and drug development sectors.
Founders & leadership
Board
Investors · 4
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: F-Prime Capital's portfolio page · Not right? Tell us
How we know: Northern Light Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$120M disclosed across 1 round · 2020
▶$120MraisedNov 2020 · 14 investors · BiotechnologyRule 506(b)
- Ming YanExecutive Officer, Director
- Jiecheng ZhangDirector
- Allen PoirsonDirector
- Andrew LevinDirector
- Feng DengDirector
- Jack BallDirector
- Wenbin JiangExecutive Officer, Director
- Offering amount
- $120M
- Amount sold
- $120M
- Minimum investment
- $1
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 2
Companies working in the same space as Cytek Biosciences.
Frequently asked questions
- What does Cytek Biosciences do?
- Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets. The company serves the life sciences research and drug development sectors.
- Who founded Cytek Biosciences?
- Cytek Biosciences was founded by Wenbin Jiang, Ph.D., Wenbin Jiang.
- Who are Cytek Biosciences's investors?
- Cytek Biosciences's investors include 3E Bioventures Capital, F-Prime Capital, Northern Light Venture Capital, RA Capital.
- How much funding has Cytek Biosciences raised?
- Cytek Biosciences has disclosed $120M raised across 1 round.
- Where is Cytek Biosciences headquartered?
- Cytek Biosciences is headquartered in Bellevue, US.